Iraqi Doctors Soak Up Cancer Knowledge In JordanJune 28, 2004Thirty-two Iraqi Surgeons, Medical Oncologists and Senior Nurses travelled to the King Hussein Cancer Center in Amman, Jordan at the beginning of June to participate in a Seminar on Cancer Management. The Iraqi Doctors and Senior Nurses travelled in convoy from all parts of Iraq, under the auspices of British Council to Jordan, where they spent 5 days learning new techniques in head and neck cancer management. The Seminar was organised by Brian Conroy a Visiting Research Fellow at the University of Surrey's Bio-Medical Engineering Centre. Brian is the Honorary Secretary of the Norman Rowe Educational Trust, a Foundation that is committed to providing humanitarian aid to those in need. "The Iraqi doctors were very reserved at first, but they did open up during the question period. It soon became apparent the facilities and working conditions in Iraq, are very poor, compared to the UK. The medical and surgical skills, of those attending from Iraq, proved to be very high, but they lack up-to-date information of the modern advances, in the management of cancer, and there is a lack of technological support" said Brian Conroy. "Clinical resources, such as Chemotherapy Drugs, Radiation and Diagnostic Facilities, are in very short supply, often influencing the level of treatment that can be provided. Apparently, there is also a grave shortage of Clinical and Scientific Text Books and Journals, throughout the Country." "We hope that our recent activity aimed at helping colleagues in Iraq, will stir the imagination of other UK Medical and Surgical Professionals, to provide similar courses in other clinical fields, benefit the retraining of Iraqi Medical Staff, to help them in their future rebuilding of Clinical Services." All aspects of Head and Neck Cancer Management were covered in the Scientific Programme; from the Epidemiology of Cancer: 'its Identification; Location and extent of Disease Progression:' Optimum Treatment Regimes to Rehabilitation and Restoration. Special sessions on the role of the Macmillian Nurse, and Speech Therapy for the Post resection patient were of particular interest to all the delegates attending the Seminar. The Seminar was held under the Patronage of her Majesty Queen Noor of Jordan, who recently received an Honorary Doctorate Degree from the University of Surrey, in recognition of her long-standing commitment to improve Health Care and Education of those in under privileged countries. Her Majesty Queen Noor said in an opening address to the Delegates and Speakers: "The King Hussein Foundation strongly supports all endeavours to improve cancer treatment through International co-operation. Civilised societies have always been willing to share knowledge and resources freely, for the glory of knowledge itself, and to improve Health, Welfare, Education and Prosperity, especially for those most in need. You are here to advance human knowledge, in ways that will ease human suffering, and you are doing it by working together, you are demonstrating compassion at a time when the world needs it most, let us hope that others follow your example. " Surrey, University of |
|||||||||||||||||||||
| Related Cancer Current Events and Cancer News Articles Menopause-cardiology consensus statement on cardiovascular disease and on HRT A menopause-cardiology consensus statement has called for direct action to prevent cardiovascular disease (CVD) in menopausal women. The statement also concludes that there is little evidence of increased CVD risk in taking HRT. Other Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival, UAB Researchers Say A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer. Multiple health concerns surface as winter, vitamin D deficiences arrive A string of recent discoveries about the multiple health benefits of vitamin D has renewed interest in this multi-purpose nutrient, increased awareness of the huge numbers of people who are deficient in it, spurred research and even led to an appreciation of it as "nature's antibiotic." AIDS research reveals a lack of family-planning programs in Uganda University of Alberta graduate student Jennifer Heys wants to make her message clear: there needs to be more education in Ugandan communities about contraception. Possible Link Studied Between Childhood Abuse and Early Cellular Aging Children who suffer physical or emotional abuse may be faced with accelerated cellular aging as adults, according to new research from Butler Hospital and Brown University. Rare pancreatic cancer patients may live longer when treated with radiation therapy Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy. Researchers Identify Role of Gene in Tumor Development, Growth and Progression Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. Saving the single cysteine: new antioxidant system found We've all read studies about the health benefits of having a life partner. The same thing is true at the molecular level, where amino acids known as cysteines are much more vulnerable to damage when single than when paired up with other cysteines. Gene mismatch influences success of bone marrow transplants A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics. Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||